Heterozygous deletion of the OPA1 gene in patients with dominant optic atrophy
- 254 Downloads
Several OPA1 variants cause dominant optic atrophy (DOA), the most common hereditary optic atrophy. Here, we describe a newly discovered OPA1 deletion in 3 patients with DOA.
A female proband, her brother, and her mother underwent complete ophthalmologic examinations that included optical coherence tomography and visual field assessments using a Humphrey Field Analyzer with both standard automated perimetry (SAP) and short-wavelength automated perimetry (SWAP). Genomic DNA from each patient was examined to detect genomic rearrangements involving OPA1; the genetic analysis involved both multiplex ligation probe amplification and conventional Sanger sequencing.
Each patient had temporal optic disc pallor and significant thinning of the retinal nerve fiber layer in both eyes, although there was phenotypic variability among the patients that ranged from asymptomatic to moderately decreased visual acuity. For the affected brother and mother, the mean deviation values from SAP were within the normal range, whereas those from SWAP were significantly below the normal range (P < .05). The genetic analysis identified a newly discovered heterozygous deletion that encompasses exons 9–14 and revealed a breakpoint junction that directly connects intron 8 to intron 14.
This newly described deletion is likely to lead to loss of function in the functionally important GTPase domain encoded by exons 9–16, and the heterozygosity suggested that haploinsufficiency caused the phenotypes. The deletion may be associated with mild DOA phenotypes ranging from asymptomatic to moderately decreased visual acuity.
KeywordsHereditary optic neuropathy OPA1 Genetics Mutation
This study was supported in part by JSPS Kakenhi Grants [Nos. 26462674 (KT) and 25462738 (TH)] and by the Japan Agency for Medical Research and Development, Practical Research Project for Rare/Intractable Diseases [No. 15ek0109072h0002 (TI)].
Conflicts of interest
T. Hayashi, None; H. Sasano, None; S. Katagiri, None; K. Tsunoda, None; S. Kameya, None; M. Nakazawa, None; T. Iwata, None; H. Tsuneoka, Grants (Abbott Medical Optics, Alcon, Daiichi Sankyo, Kowa, MSD, NIDEK, Otsuka, Santen, Senju), Lecture fees (Abbott Medical Optics, Alcon, Bausch & Lomb, HOYA, Kowa, NIDEK, Otsuka, Pfizer, Santen, Senju).
- 6.Nakamura M, Lin J, Ueno S, Asaoka R, Hirai T, Hotta Y, et al. Novel mutations in the OPA1 gene and associated clinical features in Japanese patients with optic atrophy. Ophthalmology. 2006;113(483–8):e1.Google Scholar
- 21.Barboni P, Savini G, Cascavilla ML, Caporali L, Milesi J, Borrelli E, et al. Early macular retinal ganglion cell loss in dominant optic atrophy: genotype–phenotype correlation. Am J Ophthalmol. 2014;158(628–36):e3.Google Scholar